Shaperon said Monday that it has submitted an investigational new drug (IND) application for a U.S. phase 2 clinical trial of its atopic dermatitis drug candidate NuGel to the U.S. Food and Drug Administration.The multinational phase 2 study will evaluate the drug’s pharmacokinetics, safety, tolerab
Next&Bio, a company specializing in organoid-based drug discovery, said on Monday that its pancreatic cancer drug susceptibility test has been designated an innovative medical technology. The company said that the test had become Korea’s first organoid-based innovative medical technology, paving the
The share prices of Covid-19 diagnostic kit makers are rising amid concerns about the resurgence of the virus.As of 11:10 a.m., Seegene was trading at 23,350 won ($18.36), up 8.86 percent from the previous trading day. Stocks of other diagnostic kit makers also rose, as shown by SD Biosensor (11,800
AstraZeneca's rare disease unit Alexion has acquired Pfizer's gene therapy portfolio following its recent acquisition of genomic medicine pioneer LogicBio, exposing its ambition to become an industry leader in genomic medicine.AstraZeneca said Friday that Alexion had acquired Pfizer's portfolio of p
Philips Korea said on Monday that it signed a memorandum of understanding with medical artificial intelligence company, Aitrics, to build a smart critical care management solution using AI. The two companies plan to build a Korean smart critical care solution based on their technologies and actively
KoBioLabs has suspended the phase 2a clinical trial of its ulcerative colitis (UC) drug candidate KBL697 (pipeline name: KBLP-007).KoBioLabs said in a public notice last Wednesday that it had voluntarily withdrawn its phase 2a clinical trial of KBL697. In July 2021, KoBioLab received approval for it
The incidence of depression in patients suffering from pain is increasing, a study said. Depression is also associated with mortality, so it is necessary to manage depression in patients with pain conditions.A team of researchers from Seoul National University Bundang Hospital analyzed data from the
Hospitals made about 60,000 illegal prescriptions for medical narcotics and other restricted drugs in the wake of the telemedicine, temporarily allowed in response to the Covid-19 pandemic, a lawmaker said.Rep. In Jae-geun of the Democratic Party of Korea released the report on Friday based on his a
A clinical study has won regulatory approval to treat patients with extensive-disease (ED) small cell lung cancer (SCLC) by using self-derived natural killer (NK) cells in combination with chemotherapy.The Ministry of Health and Welfare said Friday that it decided to approve the trial at the seventh
CJ Bioscience said on Friday that it plans to launch its microbiome analysis platform, EzBiome Bioinformatics App (EzBiome), next year.Since July, the company has been conducting a pilot service of EzBiome by opening some functions to bio-industry officials and university professors. On Wednesday, t
Kakao Healthcare has taken the first step toward building a data-driven leading model for clinical trials.Kakao Healthcare said Thursday that a consortium it formed with Kyung Hee Medical Center has been selected as a research conductor to develop new technologies for smart clinical trials. The cons
Korea Biotechnology Industry Organization (Korea BIO) said on Thursday that it sincerely welcomed the government's revision of the tax law to support global competitiveness in the biopharmaceutical sector.Currently, national strategic technologies include only vaccines in the bio sector, but the rev
"What the hell are we supposed to do?"Many in the medical community said so after the government decided to stop reimbursing Covid-19 treatments and sharply reduce the number of people who can be tested with reimbursement from August.The critics said the government would end up abandoning Covid-19 p
Jung Ki-suck, the new president of the National Health Insurance Service (NHIS), has revealed his intention to change the overall reimbursement system to prevent erosion in the coverage of essential medical services.For instance, Jung will increase reimbursements for surgeries and other medical prac
Coreline Soft said on Friday that inquiries for its AVIEW Pseudomyzation Sever are increasing in response to the Ministry of Health and Welfare (MOHW) announcement to strengthen medical data security policies.While the digitalization of the medical industry has advanced the quality of medical servic
Janssen Korea, the pharmaceutical unit of Johnson & Johnson in Korea, said Thursday its multiple myeloma drug Tecvayli (teclistamab) won approval from the Ministry of Food and Drug Safety as monotherapy to treat adult patients with relapsed or refractory multiple myeloma who have received at least t
Niusha Shariloo, a 28-year-old Iranian, arrived in Korea in 2019 to pursue a Korean language course at Seoul National University (SNU). However, fate had other plans for her, as she found herself extending her stay for three years to pursue a Master of Science in Cancer Genomics and Medical Cancer B
Daewoong Pharmaceutical said on Thursday that it recorded 307.1 billion won (approximately $ 240.4 million) in sales and 36.2 billion won in operating profit in the second quarter, up 4.5 percent and 7.8 percent, respectively, from the same quarter last year. The company attributed the increase in o
Seventeen university hospitals have been disciplined by the Personal Information Protection Commission (PIPC) for leaking patient information to pharmaceutical companies.The commission said Thursday that it has advised 17 university hospitals that violated personal information protection laws to imp
MedPacto, a Korean drug developer, said its cancer drug candidate vactosertib has obtained the European Medicines Agency’s (EMA) orphan medicinal product designation (OPD).The EMA’s OPD entitles the drug to a full or partial fee reduction in the authorization process, the company said. In 2021, vact